Phase II trial of doxorubicin (A) vs paclitaxel (T) vs doxorubicin and paclitaxel (A+T) as first-line therapy for metastatic breast cancer: An intergroup trial. - Sledge,G.W.; Neuberg,D.; Ingle,J.. (Proc Am Soc Clin Oncol, 1997)